Conformational changes in monoamine oxidase A in response to ligand binding or reduction

被引:23
作者
Hynson, RMG
Kelly, SM
Price, NC
Ramsay, RR [1 ]
机构
[1] Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9ST, Fife, Scotland
[2] Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2004年 / 1672卷 / 01期
基金
英国生物技术与生命科学研究理事会;
关键词
circular dichroism; aromatic amino acid; difference spectra; flavin reduction; covalent modification; monoamine oxidase A;
D O I
10.1016/j.bbagen.2004.02.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structure of monoamine oxidase B [Nat. Struct. Biol. 9 (2002) 22] revealed three aromatic amino acid residues within contact distance of the flavin cofactor and a large number of aromatic residues in the substrate binding site. Circular dichroism (CD) spectroscopy can detect alterations in the environment of aromatic residues as a result of ligand binding or redox changes. CD spectra of MAO A indicate that a small inhibitor such D-amphetamine perturbs the aromatic residues very little, but binding of the larger pirlindole (2,3,3a,4,5,6-hexahydro-8-methyl- 1H-pyrazino[3,2, 1-j,k] carbazole hydrochloride) causes spectral changes consistent with the alteration of the environment of tyrosine and tryptophan residues in particular. Reduction of the flavin cofactor induces large enhancement of the CD signals in the aromatic region (260-310 nm). When covalent modification of the flavin by clorgyline accompanies reduction, the perturbation is even greater. In contrast to the static picture offered by crystallography, this study reveals changes in the aromatic cage on ligand binding and suggests that reduction of the cofactor substantially alters the environment of aromatic residues presumably near the flavin. In addition, the covalently modified reduced MAO A shows significant differences from the substrate-reduced enzyme. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:60 / 66
页数:7
相关论文
共 18 条
[1]   Structure-function relationships in flavoenzyme-dependent amine oxidations. A comparison of polyamine oxidase and monoamine oxidase. [J].
Binda, C ;
Mattevi, A ;
Edmondson, DE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :23973-23976
[2]   Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders [J].
Binda, C ;
Newton-Vinson, P ;
Hubálek, F ;
Edmondson, DE ;
Mattevi, A .
NATURE STRUCTURAL BIOLOGY, 2002, 9 (01) :22-26
[3]   Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures [J].
Binda, C ;
Li, M ;
Hubálek, F ;
Restelli, N ;
Edmondson, DE ;
Mattevi, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) :9750-9755
[4]   INTERACTIONS OF MONOAMINE-OXIDASE WITH SUBSTRATES AND INHIBITORS [J].
DOSTERT, PL ;
BENEDETTI, MS ;
TIPTON, KF .
MEDICINAL RESEARCH REVIEWS, 1989, 9 (01) :45-89
[5]   Characterization of cholesterol oxidase from Streptomyces hygroscopicus and Brevibacterium sterolicum [J].
Gadda, G ;
Wels, G ;
Pollegioni, L ;
Zucchelli, S ;
Ambrosius, D ;
Pilone, MS ;
Ghisla, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (02) :369-376
[6]   Analysis of conserved active site residues in monoamine oxidase A and B and their three-dimensional molecular modeling [J].
Geha, RM ;
Chen, K ;
Wouters, J ;
Ooms, F ;
Shih, JC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (19) :17209-17216
[7]   KINETIC-STUDIES ON THE CATALYTIC MECHANISM OF LIVER MONOAMINE-OXIDASE [J].
HUSAIN, M ;
EDMONDSON, DE ;
SINGER, TP .
BIOCHEMISTRY, 1982, 21 (03) :595-600
[8]   Monoamine oxidase A inhibitory potency and flavin perturbation are influenced by different aspects of pirlindole inhibitor structure [J].
Hynson, RMG ;
Wouters, J ;
Ramsay, RR .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (11) :1867-1874
[9]   SOME OBSERVATIONS UPON A NEW INHIBITOR OF MONOAMINE OXIDASE IN BRAIN TISSUE [J].
JOHNSTON, JP .
BIOCHEMICAL PHARMACOLOGY, 1968, 17 (07) :1285-&
[10]  
Kahn P C, 1979, Methods Enzymol, V61, P339